OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
LibPubMedia1@gmail.com
OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
LibPubMedia1@gmail.com
J Venom Res
Open-access
Aptamers
Open-access
Aptamers 2019
03-04 April 2019, Oxford
Submit a manuscript

Blog Full Right Sidebar

Caption Aligned Here
A wonderful serenity has taken possession of my entire soul, like these sweet mornings of spring which I enjoy with my whole heart. I am alone, and feel the charm of existence in this spot, which was created for the bliss of souls like mine. I am so happy, my dear friend, so absorbed in the...
Read More
RIBOMIC Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies called the RiboART System. RIBOMIC has been promoting the pharmaceutical discovery program in collaboration with Otsuka Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., The University of Tokyo, and some other...
Read More
Aptamer Solutions Ltd: Continued success and growth has enabled Aptamer Group to restructure its Scientific Operations team. Increasing interest in the development of aptamers against small molecule targets has led to the formation of a dedicated scientific team. This is in addition to the existing team focused on aptamer generation against larger targets (proteins, viruses, cells...
Read More
PROTOCOL/METHOD ISSN: 2514-3247 Aptamers (2018), Vol 2, in press Published online: 12 June 2018 Full Text Access  Sladjana Slavkovic and Philip E. Johnson* Department of Chemistry and Centre for Research on Biomolecular Interactions, York University, Toronto, Ontario, Canada, M2R 1A1 *Correspondence to: Philip Johnson, Email: pjohnson@yorku.ca, Tel: 1 416 736 2100 x33119 Received: 31 January 2018 |...
Read More
We are delighted to announce that Professor Günter Mayer will chair Aptamers 2019.  Professor Mayer is the Professor of Chemical Biology at Life and Medical Sciences Institute (LIMES), Bonn University, Germany, and heads an international team of researchers investigating the use of aptamer technology in understanding biological phenomena and developing nucleic acids as drugs or drug targets in...
Read More
Fee Structure Early bird and group discounts are available.  Register 3 for the price of 2 until 31 December 2018 (cheapest registration free – Promocode: 3for2)* Register 4 for the price of 3 any time (cheapest registration free – Promocode: 4for3)* Fees apply to payments made on or before the indicated deadlines and not to the...
Read More
1 2 3 36

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Recent News

Ribomic Inc (Japan) – Our Gold Sponsor
December 8, 2018
Aptamer Group (UK) – Our Gold Sponsor
December 8, 2018
Isothermal titration calorimetry studies of aptamer-small molecule interactions: practicalities and pitfalls
June 12, 2018

Recent Cases